Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 24. Juni 2017
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1523  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 30451  
Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
PLoS One
Iino C, Shimoyama T, Igarashi T, Aihara T, Ishii K, Sakamoto J, Tono H, Fukuda S.
PMID: 28644836 [PubMed - in process]

A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Tumour Biol
Yao K, Wang Q, Jia J, Zhao H.
PMID: 28639886 [PubMed - in process]

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer.
Cancer Med
Shrestha B, Sun Y, Faisal F, Kim V, Soares K, Blair A, Herman JM, Narang A, Dholakia AS, Rosati L, Hacker-Prietz A, Chen L, Laheru DA, De Jesus-Acosta A, Le DT, Donehower R, Azad N, Diaz LA, Murphy A, Lee V, Fishman EK, Hruban RH, Liang T, Cameron JL, Makary M, Weiss MJ, Ahuja N, He J, Wolfgang CL, Huang CY, Zheng L.
PMID: 28639410 [PubMed - as supplied by publisher]

Adjuvant treatment for pancreatic ductal carcinoma.
Clin Transl Oncol
Macarulla T, Fernández T, Gallardo ME, Hernando O, López AM, Hidalgo M.
PMID: 28639051 [PubMed - as supplied by publisher]

Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.
World J Clin Oncol
Guo S, Contratto M, Miller G, Leichman L, Wu J.
PMID: 28638792 [PubMed - in process]

Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.
World J Clin Oncol
Tchio Mantho CI, Harbuzariu A, Gonzalez-Perez RR.
PMID: 28638788 [PubMed - in process]

ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
Int J Med Sci
Botti G, Malzone MG, La Mantia E, Montanari M, Vanacore D, Rossetti S, Quagliariello V, Cavaliere C, Di Franco R, Castaldo L, Ametrano G, Cappuccio F, Romano FJ, Piscitelli R, Pepe MF, D'Aniello C, Facchini G.
PMID: 28638271 [PubMed - in process]

Role of surgery in pancreatic cancer.
World J Gastroenterol
Buanes TA.
PMID: 28638216 [PubMed - in process]

Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Chin J Cancer
Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J.
PMID: 28637502 [PubMed - in process]

Experimental study on the therapeutic effect and underlining mechanisms of positron in pancreatic cancer cells.
Wang Y, Li M, Diao R, Tung B, Zhang D, Li Y.
PMID: 28636995 [PubMed - as supplied by publisher]

A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo.
Cancer Chemother Pharmacol
Ueno M, Li CP, Ikeda M, Ishii H, Mizuno N, Yamaguchi T, Ioka T, Oh DY, Ichikawa W, Okusaka T, Matsuyama Y, Arai D, Chen LT, Park YS, Furuse J.
PMID: 28634650 [PubMed - as supplied by publisher]

Pancreatic Cyst Fluid Vascular Endothelial Growth Factor A and Carcinoembryonic Antigen: A Highly Accurate Test for the Diagnosis of Serous Cystic Neoplasm.
J Am Coll Surg
Carr RA, Yip-Schneider MT, Dolejs S, Hancock BA, Wu H, Radovich M, Schmidt CM.
PMID: 28633941 [PubMed - as supplied by publisher]

Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review.
Eur J Cancer
Petrelli F, Inno A, Ghidini A, Rimassa L, Tomasello G, Labianca R, Barni S, GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) and Cremona Hospital..
PMID: 28633088 [PubMed - as supplied by publisher]

Metastatic tonsillar squamous cell carcinoma masquerading as a pancreatic cystic tumor and diagnosed by EUS-guided FNA.
Diagn Cytopathol
Glass R, Andrawes SA, Hamele-Bena D, Tong GX.
PMID: 28631390 [PubMed - as supplied by publisher]

Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case-cohort study.
Eur Radiol
Gonoi W, Hayashi TY, Okuma H, Akahane M, Nakai Y, Mizuno S, Tateishi R, Isayama H, Koike K, Ohtomo K.
PMID: 28631079 [PubMed - as supplied by publisher]

How Schwann cells facilitate cancer progression in nerves.
Cell Mol Life Sci
Deborde S, Wong RJ.
PMID: 28631007 [PubMed - as supplied by publisher]

Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors.
J Surg Oncol
Skelton RA, Javed A, Zheng L, He J.
PMID: 28628715 [PubMed - as supplied by publisher]

Tumor-targeting Salmonella typhimurium A1-R promotes tumoricidal CD8+ T cell tumor infiltration and arrests growth in a syngeneic pancreatic cancer orthotopic mouse model.
J Cell Biochem
Murakami T, Hiroshima Y, Zhang Y, Zhao M, Kiyuna T, Hwang HK, Miyake K, Homma Y, Mori R, Matsuyama R, Chishima T, Ichikawa Y, Tanaka K, Bouvet M, Endo I, Hoffman RM.
PMID: 28628234 [PubMed - as supplied by publisher]

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management.
Front Physiol
Pimienta M, Edderkaoui M, Wang R, Pandol S.
PMID: 28626429 [PubMed - in process]

Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
Life Sci
Li R, Peng C, Zhang X, Wu Y, Pan S, Xiao Y.
PMID: 28625359 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 30451    Seite 1 von 1523  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1